This month, the Big Ten Cancer Research Consortium highlights the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as our featured member. Daniela Matei, MD, the Diana, Princess of Wales Professor of Cancer Research, professor of Hematology / Oncology and Gynecologic Oncology at Northwestern University Feinberg School of Medicine, and co-leader of the Translational Bridge Program at the Lurie Cancer Center, was featured in the story, “From Behind the Iron Curtain to a Career in Gynecologic Cancer Research,” in the ASCO Post.
About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The goal of the Big Ten Cancer Research Consortium is to create a unique team-research culture to drive science rapidly from ideas to new approaches to cancer treatment. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.
About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org.
February 1, 2021: The Big Ten Cancer Research Consortium recently appointed Elisavet Paplomata, MD, assistant professor of hematology/oncology at University of Wisconsin School of Medicine, and Eugenia Girda, MD, FACOG, assistant professor of obstetrics, gynecology, and reproductive sciences at Rutgers Robert Wood Johnson Medical School, as new co-chairs of the Big Ten CRC’s Gynecologic Clinical Trial Working Group. Their leadership will support collaboration and mentoring opportunities within the working group, and will guide the development of Big Ten CRC gynecologic clinical trials, from initial LOI submission, review, and approval, to expert feedback throughout the life of each ongoing study, and final publication. Read More
January 24, 2021: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights emerging research, new appointments and initiatives that support advancement in the health and treatment of those with cancer. Read More
January 8, 2021: Monika Joshi, MD, MRCP, associate professor of medicine at Penn State College of Medicine and a medical oncologist at Penn State Cancer Institute, has been appointed as the chief scientific officer of the Big Ten Cancer Research Consortium. She succeeds Ruth O’Regan, MD, who now serves as chair of the Department of Medicine at the University of Rochester. The Big Ten CRC announced Dr. Joshi’s appointment during the consortium’s Virtual Summit on January 8. She will serve a three-year, renewable term in her new role. “I’m excited and very honored to be appointed as the CSO for the prestigious Big Ten Cancer Research Consortium,” Dr. Joshi said. “I want to... Read More
January 8, 2021: The Big Ten Cancer Research Consortium (Big Ten CRC) honored Indiana University and Patrick J. Loehrer, Sr., MD, director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, with two new awards during the Big Ten CRC Virtual Summit, hosted by the Cancer Center at Illinois, on Friday, January 8. The Big Ten Cancer Research Consortium Institutional Leadership Award is a new award that will be presented annually to the member institution that provides the greatest overall contribution to the success of the Big Ten CRC. The award is given to the institution that led all member institutions in combined Clinical Trial Working Group participation and patient enrollment on Big... Read More
December 28, 2020: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights recently published research, grants, professional appointments, oral presentations, and developments in basic scientific research across Big Ten cancer centers and universities. Stay current on what’s happening within our Big Ten universities. Read More
December 23, 2020: In a recent holiday post on his blog Holden the Line on Cancer, George Weiner, MD, director of the University of Iowa Holden Comprehensive Cancer Center, reflects on the resilience, creativity, and enduring commitment that has kept research collaborations strong throughout this tumultuous year. As one example, Dr. Weiner writes about the newly introduced Big Ten CRC Grand Rounds: "One of the primary goals of an academic cancer center is to train the next generation of cancer clinicians and researchers. Our approach to such education has been changed, but not halted, by the pandemic. I continue to... Read More
December 15, 2020: After more than 20 years in cancer research, Borys Hrinczenko, MD, PhD, sees a bright future. As a lung cancer specialist at the Michigan State University Breslin Cancer Center, he has led numerous clinical trials and helped pioneer new therapies, including checkpoint inhibitors, harnessing the body’s immune system against lung cancer. Twenty years ago, he could offer his lung cancer patients few viable treatments. More recently, “I’ve had patients who have done quite well” on checkpoint inhibitors, Hrinczenko said. That includes a small group of long-term survivors with advanced lung cancer. He expects more breakthroughs as the Breslin Cancer Center looks forward to moving into a new... Read More
November 16, 2020: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights several new research studies, study publications, grant awards, professional appointments, and an endowment established to support cancer research. Learn what’s happening across the Big Ten CRC. Read More
November 3, 2020: This month, the Big Ten Cancer Research Consortium highlights the University of Michigan Rogel Cancer Center as our featured member. Rogel Cancer Center member Ajjai Alva, MBBS, is an associate professor of hematology/oncology and member of the Big Ten CRC's Genitourinary Clinical Trial Working Group. He has participated in four Big Ten CRC trials with a few more in the pipeline. Dr. Alva shares why he is glad to be part of the Big Ten Cancer Research Consortium. "Cancer Research is evolving rapidly with major new advances and that's... Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube